Broadwood Partners, L.P.'s Form 4 filing
Insight Molecular Diagnostics Inc. (IMDX) · filed Apr 20, 2026
- Accession no.
- 0000919574-26-002306
- Filed
- Apr 20, 2026, 7:24 PM ET
- Trade date
- Apr 16-20, 2026
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 6 non-derivative transactions and 0 derivative transactions. Open-market purchases total $652.9K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Broadwood Partners, L.P.CIK 0001278386 | 10% Owner |
| Broadwood Capital IncCIK 0001278387 | 10% Owner |
| Bradsher Neal CCIK 0001278388 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 16, 2026 | Common Stock, no par value | PPurchaseAcquired | +102,057 | $3.45 | +$351,657.8 | 12,033,896 | Direct | |
| Apr 16, 2026 | Common Stock, no par value | PPurchaseAcquired | 0 | $0.00 | $0 | 12,033,896 | Indirect | |
| Apr 17, 2026 | Common Stock, no par value | PPurchaseAcquired | +40,114 | $3.57 | +$143,251.11 | 12,074,010 | Direct | |
| Apr 17, 2026 | Common Stock, no par value | PPurchaseAcquired | 0 | $0.00 | $0 | 12,074,010 | Indirect | |
| Apr 20, 2026 | Common Stock, no par value | PPurchaseAcquired | +40,690 | $3.88 | +$157,966.72 | 12,114,700 | Direct | |
| Apr 20, 2026 | Common Stock, no par value | PPurchaseAcquired | 0 | $0.00 | $0 | 12,114,700 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.